Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 12

gbaf1news

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gileads Executive Vice President and Chief Financial Officer and John McHutchison, AO, MD, Gileads Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami on Tuesday, March 12 at 10:45 a.m. Eastern Time.

The audio portion of the fireside chat will be accessible live through the companys Investors page at www.gilead.com/investors. Please connect to the companys website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the companys website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Sung Lee
Investor Relations
(650) 524-7792